Key result
A worksite health promotion program resulted in a non-significant mean blood pressure change difference of -1.1 mmHg at 12 months compared to control companies.
Why the study?
Cardiovascular disease is increasingly prevalent in low- and middle-income countries, but the efficacy and sustainability of worksite health promotion programs for blood pressure reduction in these settings have yet to be determined.
Does a multicomponent worksite health promotion program reduce blood pressure in Mexican workers?
Observational (n=2,002)
Open-label
Non-randomized (assigned at company level)
Yes
Does a multicomponent worksite health promotion program reduce blood pressure in Mexican workers?
Mean Difference: -1.1 (95% CI -2.9–0.6)
p-value: p=0.20
A worksite health promotion program in Mexico produced modest, statistically uncertain blood pressure reductions overall at 12 months, though substantial benefits were noted for diabetic subgroups.
Does not support routine worksite program adoption for BP control; leaves open subgroup benefits in diabetes pending randomized trials.
Background: Cardiovascular disease is becoming increasingly prevalent in low and middle-income countries (LMIC), and high blood pressure (BP) is one of the main risk factors. The efficacy and sustainability of worksite health promotion (WHP) programs for BP reduction in LMIC have yet to be determined. Methods: This non-randomized company-based trial evaluated 6- and 12-months effects of a WHP intervention on BP among 2,002 participating workers from seven Mexican companies. Intervention and control groups were assigned at the company level. The intervention included nutrition counseling, physical exercise, and stress management components. Mixed models assessed differences in BP change between intervention and control companies in intent-to-treat (ITT), per-protocol (PerP), and as-treated (AsTr) analyses, and also within-group changes stratified by company, intervention component, and baseline cardiovascular risk factor levels. All analyses were adjusted for potential confounders. We accounted for missing data and loss to follow-up using inverse probability of censoring weighting. Results: ITT analyses revealed mean BP change differences of −1.1 mmHg at 12 months (95% CI: −2.9; 0.6) in intervention companies relative to control companies. PerP and AsTr analyses confirmed this finding. Within-group analyses showed consistent BP reductions at both 6 and 12 months. Substantial differences in BP changes ranging from diastolic −6.1 mmHg, (95% CI: −11.2; −1.2) to systolic −13.0 mmHg (95% CI: −16.0; −10.1) were found among individuals with diabetes at baseline in intervention companies relative to control companies. Conclusion: After 1 year, WHP was associated with modest but uncertain BP reductions. Substantial reductions were mainly observed among diabetic workers.
No takes yet. Share an insight, caveat, or question.
Garcia‐Rojas et al. (2021) conducted an observational in General worker population (cardiovascular disease prevention) (n=2,002). Worksite health promotion program (nutrition, exercise, stress management) vs. Control companies receiving no active intervention was evaluated on Mean blood pressure change difference at 12 months (Mean difference -1.1 mmHg, 95% CI -2.9, 0.6, p=0.20). A worksite health promotion program resulted in a non-significant mean blood pressure change difference of -1.1 mmHg at 12 months compared to control companies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: